Phase I Study of Weekly Irinotecan Combined with Weekly Cisplatin in Patients with Advanced Solid Tumors

Publisher： Karger

E-ISSN： 1421-9794|48|4|205-210

ISSN： 0009-3157

Source： Chemotherapy, Vol.48, Iss.4, 2002-09, pp. : 205-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

By  

Chemotherapy, Vol. 55, Iss. 6, 2009-12 ,pp. : 441-445

Karger

Access to resources Recommend Favorite

A Phase I Study of Oral Uracil-Tegafur Prior to Weekly Intravenous Gemcitabine in Patients with Advanced Pancreatic Cancer

By  

Chemotherapy, Vol. 52, Iss. 2, 2006-04 ,pp. : 98-102

Karger

Access to resources Recommend Favorite

Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

By  

Chemotherapy, Vol. 50, Iss. 6, 2004-12 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

Oxaliplatin with Weekly Bolus 5-Fluorouracil and Leucovorin in Pretreated Advanced Colorectal Cancer Patients: A Phase II Study

By  

Chemotherapy, Vol. 49, Iss. 4, 2003-07 ,pp. : 194-199

Karger

Access to resources Recommend Favorite

Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 197-203

Karger

Access to resources Recommend Favorite